Illumina Applauds FDA’s Issuance of Draft Guidances
News Jul 08, 2016
Illumina, Inc. has announced that it supports the Food and Drug Administration (FDA) in their efforts to provide a flexible and streamlined approach to the oversight of next generation sequencing (NGS) diagnostic tests, as represented by FDA’s release of two new draft guidance documents. The FDA draft guidances are part of the larger Precision Medicine Initiative announced by President Obama in his 2015 State of the Union address.
“This is an important step forward,” said Francis deSouza, President and CEO of Illumina. “We support the proactive actions the FDA is taking to recognize the benefits of next generation sequencing and provide appropriately flexible and adaptive regulatory oversight of these tests, while accommodating the rapid evolution of NGS technologies.”
Next generation sequencing can examine millions of DNA variants at a time, reading a patient’s DNA to detect genomic variations that determine whether a person has or is at risk of disease and informing treatment decisions. Illumina will continue to partner with customers and work with FDA to collectively enable the promise of genetic medicine by driving the adoption of next generation sequencing.
The two FDA draft guidance documents, Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases and Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing Based In Vitro Diagnostics, were released July 6th.
The Genes That Make Quorn a Fungal Food FavoriteNews
The meat substitute Quorn is derived from a fungus called Fusarium venenatum. A very similar fungus, F. graminearum, is one of the world's most damaging crop diseases. A new genome study shows why one fungus makes food, and the other destroys it.READ MORE
Comments | 0 ADD COMMENT
6th International Conference on Neurodegenerative Disorders and Stroke
Oct 22 - Oct 23, 2018
16th Annual Conference on Laboratory Medicine and Pathology
Sep 17 - Sep 18, 2018